• 1. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 2. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 5. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

Introduction to 7-Iodo-3,4-dihydro-2H-1,5-benzodioxepine (CAS No. 306934-90-7)

7-Iodo-3,4-dihydro-2H-1,5-benzodioxepine (CAS No. 306934-90-7) is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This heterocyclic molecule, characterized by its iodine substituent and benzodioxepine core structure, has garnered considerable attention due to its versatile applications in drug discovery and molecular pharmacology. The compound's unique structural features make it a valuable scaffold for developing novel therapeutic agents targeting various biological pathways.

The benzodioxepine moiety in 7-Iodo-3,4-dihydro-2H-1,5-benzodioxepine contributes to its remarkable pharmacological properties. Benzodioxepines are known for their ability to interact with multiple receptor systems, including serotonin and dopamine receptors, which are pivotal in modulating neurotransmitter activity. This interaction is particularly relevant in the treatment of neurological and psychiatric disorders. The presence of an iodine atom at the 7-position enhances the compound's reactivity, making it a promising intermediate for further chemical modifications and derivatization.

Recent advancements in medicinal chemistry have highlighted the potential of 7-Iodo-3,4-dihydro-2H-1,5-benzodioxepine as a lead compound for the development of innovative treatments. Studies have demonstrated its efficacy in preclinical models as a modulator of serotonin receptor activity, which is crucial for addressing conditions such as depression, anxiety, and cognitive disorders. The compound's ability to selectively bind to specific serotonin receptors without significant off-target effects makes it an attractive candidate for further clinical investigation.

In addition to its applications in neuropharmacology, 7-Iodo-3,4-dihydro-2H-1,5-benzodioxepine has shown promise in other therapeutic areas. Research indicates that this molecule may exhibit anti-inflammatory and antioxidant properties, making it a potential candidate for treating chronic inflammatory diseases and oxidative stress-related conditions. The structural flexibility of the benzodioxepine ring allows for the introduction of various functional groups, enabling the synthesis of a diverse library of derivatives with tailored pharmacological profiles.

The synthesis of 7-Iodo-3,4-dihydro-2H-1,5-benzodioxepine involves multi-step organic reactions that require precise control over reaction conditions and reagent selection. Advanced synthetic methodologies have been employed to optimize yield and purity, ensuring that the final product meets the stringent requirements of pharmaceutical research. Techniques such as palladium-catalyzed cross-coupling reactions and regioselective functionalization have been instrumental in achieving high-quality intermediates and final products.

One of the most compelling aspects of 7-Iodo-3,4-dihydro-2H-1,5-benzodioxepine is its potential as a building block for structure-based drug design. By leveraging computational modeling and molecular docking techniques, researchers can predict how this compound interacts with biological targets at the atomic level. This approach has accelerated the discovery process by allowing rapid screening of virtual libraries derived from 7-Iodo-3,4-dihydro-2H-1,5-benzodioxepine, identifying novel analogs with enhanced potency and selectivity.

The growing interest in 7-Iodo-3,4-dihydro-2H-1,5-benzodioxepine underscores its significance in modern drug development. As pharmaceutical companies continue to invest in innovative therapies targeting neurological and metabolic disorders, this compound stands out as a versatile tool with broad therapeutic implications. Its unique structural features and pharmacological properties position it as a cornerstone in the quest for next-generation treatments.

Future research directions may explore the use of 7-Iodo-3,4-dihydro-2H-1,5-benzodioxepine in combination therapies to enhance treatment outcomes. By pairing this compound with other pharmacological agents that act on different biological pathways, researchers aim to develop synergistic approaches that address complex diseases more effectively. Such collaborative strategies could pave the way for breakthroughs in treating multifactorial conditions that currently pose significant challenges to healthcare providers.

In conclusion,7-Iodo-3,4-dihydro-2H-1,5-benzodioxepine (CAS No. 306934-90-7) represents a critical advancement in pharmaceutical chemistry with far-reaching implications for medical science. Its unique structural attributes and demonstrated pharmacological activity make it a cornerstone in drug discovery efforts aimed at addressing some of today's most pressing health issues. As research continues to uncover new applications for this compound,7-Iodo-3,4-dihydro -2H -1 ,5 -benzodioxepine is poised to play an increasingly vital role in shaping the future of medicine.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)